Guardant Health Stock Investor Sentiment

GH Stock  USD 35.61  0.51  1.45%   
Under 66% of Guardant Health's investor base is looking to short. The analysis of overall sentiment of trading Guardant Health stock suggests that many investors are alarmed at this time. Guardant Health's investing sentiment shows overall attitude of investors towards Guardant Health.

Panic Vs Confidence

34

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Guardant Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Guardant Health.

Guardant Historical Sentiment

Although Guardant Health's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Guardant, such as negative comments on social media and news outlets, may cause fear in the market and push Guardant Health's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Guardant.
  

Guardant Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Guardant Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Guardant Health Historical Investor Sentiment

Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Guardant Health news discussions. The higher the estimate score, the more favorable the investor's outlook on Guardant Health.
over six months ago at benzinga.com         
FDA Advisory Panel Supports Approval Of Guardant Healths Blood Test For Colorectal Cancer Screening
benzinga news
over six months ago at seekingalpha.com         
Guardant stock jumps as FDA panel backs Shield
seekingalpha News
over six months ago at bizjournals.com         
Peninsula cancer test maker lands key nod from FDA panel, a step toward a big payday
bizjournals News
over six months ago at finance.yahoo.com         
Guardant Health Stock Trading Temporarily Halted FDA Panel to Assess Premarket Approval Application ...
Yahoo News
over six months ago at businesswire.com         
Guardant Health Stock Trading Temporarily Halted FDA Panel to Assess Premarket Approval Application ...
businesswire News
over six months ago at businesswire.com         
Guardant Health Stock Trading Temporarily Halted FDA Panel to Assess Premarket Approval Application ...
businesswire News
over six months ago at seekingalpha.com         
Guardant stock trading on hold amid AdCom vote
seekingalpha News
over six months ago at seekingalpha.com         
Guardant Health colorectal cancer screening test endorsed by FDA advisors
seekingalpha News
over six months ago at investing.com         
FDA panel reviews Guardant Healths cancer test
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer...
Yahoo News
over six months ago at businesswire.com         
FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer...
businesswire News
over six months ago at businesswire.com         
FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer...
businesswire News
over six months ago at investing.com         
Canaccord maintains Buy on Guardant Health stock, bullish on prospects
Investing News at Macroaxis
over six months ago at businesswire.com         
Riassunto Guardant Health riceve la certificazione IVDR dellUE per la tecnica di biopsia liquida Gua...
businesswire News
over six months ago at businesswire.com         
Samenvatting Guardant Health ontvangt Europese IVDR-certificering voor Guardant360 CDx vloeibare bio...
businesswire News
Far too much social signal, news, headlines, and media speculation about Guardant Health that are available to investors today. That information is available publicly through Guardant media outlets and privately through word of mouth or via Guardant internal channels. However, regardless of the origin, that massive amount of Guardant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Guardant Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Guardant Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Guardant Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Guardant Health alpha.

Guardant Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 2909 shares by Darya Chudova of Guardant Health subject to Rule 16b-3
09/09/2024
2
Dans le cadre de lESMO 2024, Guardant Health prsentera des donnes dmontrant les solides performances de sa technologie doncologie de prcision dans plusieurs typ...
09/13/2024
3
Disposition of 134 shares by John Saia of Guardant Health at 28.58 subject to Rule 16b-3
09/27/2024
4
Disposition of 11461 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3
09/30/2024
5
Disposition of 6569 shares by John Saia of Guardant Health subject to Rule 16b-3
10/02/2024
6
Guardant Health Price Target Lowered to 50.00 at Leerink Partners
10/18/2024
7
Insider Trading
10/21/2024
8
Disposition of 154 shares by Krognes Steve E. of Guardant Health subject to Rule 16b-3
10/31/2024
9
Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
11/06/2024
10
Market Participants Recognise Guardant Health, Inc.s Revenues Pushing Shares 36 percent Higher
11/08/2024
11
Disposition of 8435 shares by Clark Ian T of Guardant Health subject to Rule 16b-3
11/12/2024
12
Disposition of 2896 shares by Joyce Meghan V. of Guardant Health at 29.9017 subject to Rule 16b-3
11/13/2024
13
Acquisition by Clark Ian T of 8435 shares of Guardant Health subject to Rule 16b-3
11/14/2024
14
Disposition of tradable shares by Potter Myrtle S of Guardant Health subject to Rule 16b-3
11/15/2024
15
Disposition of 7000 shares by Kumud Kalia of Guardant Health at 29.246 subject to Rule 16b-3
11/18/2024
16
Guardant Health Inc Shares Up 5.46 percent on Nov 19
11/19/2024
17
Guardant Health Inc Shares Up 6.26 percent on Nov 22
11/22/2024
18
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Healths Col...
11/25/2024
19
Disposition of 638 shares by Kumud Kalia of Guardant Health subject to Rule 16b-3
12/01/2024

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges